Aspirin reduces adverse effects of gefitinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aspirin reduces adverse effects of gefitinib

Published:2006-04 Issue:4 Volume:17 Page:423-427
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Kanazawa Shigenori,Yamaguchi Kazuyuki,Kinoshita Yoshimi,Muramatsu Mikiko,Komiyama Yutaka,Nomura Shosaku

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference12 articles.

1. Aspirin and coronary artery disease;Maree;Thromb Haemost,2004

2. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor;Ciardiello;Clin Cancer Res,2001

3. The epidermal growth factor receptor and its inhibition in cancer therapy;Woodburn;Pharmacol Ther,1999

4. Multi institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer;Fukuoka;J Clin Oncol,2003

5. Diffuse alveolar damage after ZD1839 therapy in a patient with non-small cell lung cancer;Okamoto;Lung Cancer,2003

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in understanding cardiotoxicity of EGFR- TKIs in non-small cell lung cancer treatment and beyond;Frontiers in Pharmacology;2024-08-15

2. Nomogram prediction for the risk of venous thromboembolism in patients with lung cancer;Cancer Cell International;2023-03-05

3. Prevention of Acne-Like Eruption Caused by Panitumumab Treatment through Oral Administration of Non-steroidal Anti-inflammatory Drugs;Biological and Pharmaceutical Bulletin;2022-10-01

4. Clinical characteristics and outcomes of tyrosine kinase inhibitor-related lower GI adverse effects;Journal of Cancer Research and Clinical Oncology;2022-08-28

5. Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer;Journal of Clinical Medicine;2020-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3